Page last updated: 2024-11-12

ro 48-6791

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9953485
SCHEMBL ID7394354
MeSH IDM0272975

Synonyms (15)

Synonym
ro 48-6791
ro-48-6791
unii-nke9773pbb
172407-17-9
nke9773pbb ,
SCHEMBL7394354
AKOS027338649
ro48-6791
3-[5-[(dipropylamino)methyl]-1,2,4-oxadiazol-3-yl]-8-fluoro-5-methyl-4h-imidazo[1,5-a][1,4]benzodiazepin-6-one
3-{5-[(dipropylamino)methyl]-1,2,4-oxadiazol-3-yl}-8-fluoro-5-methyl-4,5-dihydro-6h-imidazo[1,5-a][1,4]benzodiazepin-6-one
DTXSID10938143
6h-imidazo(1,5-a)(1,4)benzodiazepin-6-one, 3-(5-((dipropylamino)methyl)-1,2,4-oxadiazol-3-yl)-8-fluoro-4,5-dihydro-5-methyl-
3-(5-dipropylaminomethyl-(1,2,4)oxadiazol-3-yl)-8-fluoro-5-methyl-5,6-dihydro-4h-imidazo(1,5-a)(1,4)benzodiazepin-6-one
Q7339202
A907544

Research Excerpts

Pharmacokinetics

Ro 48-6792 showed a considerably longer half-life than the parent compound. Pharmacokinetic variables of Ro 48- 6791 were similar for both groups.

ExcerptReferenceRelevance
" Blood samples were collected frequently for pharmacokinetic determinations (two-compartment model)."( Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
Cohen, AF; Dingemanse, J; Massarella, J; Oberyé, JJ; Roncari, G; Schoemaker, RC; Segala, P; van Gerven, JM; van Oostenbruggen, MF; Zell, M, 1997
)
0.55
" Ro 48-6792, a metabolite of Ro 48-6791, showed a considerably longer half-life than the parent compound."( Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
Cohen, AF; Dingemanse, J; Massarella, J; Oberyé, JJ; Roncari, G; Schoemaker, RC; Segala, P; van Gerven, JM; van Oostenbruggen, MF; Zell, M, 1997
)
0.84
" Pharmacokinetic variables of Ro 48-6791 were similar for both groups."( Pharmacokinetic-pharmacodynamic modelling of the EEG effects of Ro 48-6791, a new short-acting benzodiazepine, in young and elderly subjects.
Albrecht, S; Dingemanse, J; Häussler, J; Hering, W; Ihmsen, H; Schüttler, J; Schwilden, H; Zell, M, 1997
)
0.82

Compound-Compound Interactions

ExcerptReferenceRelevance
"In this randomized, double-blinded study, we compared the onset and recovery characteristics of an investigational benzodiazepine, Ro 48-6791 (when administered alone or combined with meperidine), a midazolam-meperidine combination for sedation during gastrointestinal (GI) endoscopic procedures."( Comparison of the sedation and recovery profiles of Ro 48-6791, a new benzodiazepine, and midazolam in combination with meperidine for outpatient endoscopic procedures.
Gold, J; Gold, M; Tang, J; Wang, B; White, PF, 1999
)
0.76
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (88.89)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.53 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (44.44%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (44.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]